Product Details
Product Name:
MHY-1685 |
CAS No.:
27406-31-1 |
Purity:
98.44% |
Supply Ability:
10g |
Release date:
2024/11/18 |
Product Introduction
Bioactivity
Name | MHY-1685 |
Description | MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 10 mg/mL (43.07 mM)
|
Keywords | MHY 1685 | inhibit | MHY1685 | mTOR | Inhibitor | MHY-1685 | Mammalian target of Rapamycin |
Inhibitors Related | α-Hydroxyglutaric Acid Lithium | L-Leucine | Capivasertib | Sapanisertib | Everolimus | Bimiralisib | Tacrolimus | GDC0084 | Dihydromyricetin | Rapamycin |
Related Compound Libraries | 抗肺癌化合物庫 | 經(jīng)典已知活性庫 | 抗抑郁癥化合物庫 | 激酶抑制劑庫 | 抑制劑庫 | 抗前列腺癌化合物庫 | 代謝化合物庫 | 抗衰老化合物庫 | 已知活性化合物庫 | 神經(jīng)元分化化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:168701-80-2
$296.00 / 1mg
-
CAS:759443-00-0
$112.00 / 1mg
-
CAS:915942-22-2
$82.00 / 100mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |